• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在多囊肾病进展过程中,肠道屏障功能会下降。

Intestinal barrier function declines during polycystic kidney disease progression.

作者信息

Sedaka Randee, Lovelady Caleb, Hallit Emily, Duyvestyn Branden, Shinde Sejal, Moran-Reyna Aida, Lee Goo, Yamaguchi Shinobu, Maynard Craig L, Saigusa Takamitsu

机构信息

Section of Cardio-Renal Physiology and Medicine, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Alabama, United States.

Division of Anatomic Pathology, Department of Pathology, University of Alabama at Birmingham, Alabama, United States.

出版信息

Am J Physiol Renal Physiol. 2025 Feb 1;328(2):F218-F229. doi: 10.1152/ajprenal.00058.2024. Epub 2024 Dec 18.

DOI:10.1152/ajprenal.00058.2024
PMID:39694536
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12176450/
Abstract

Most patients with autosomal dominant polycystic kidney disease (ADPKD) develop kidney cysts due to germline mutations. In the kidney, loss impairs epithelial cell integrity and increases macrophage infiltration, contributing to cyst growth. Despite its role as the body's largest inflammatory cell reservoir, it has yet to be elucidated whether a similar phenotype presents in the intestines. We hypothesize that loss of leads to a leaky intestinal epithelial barrier and increased inflammation, before rapid cystogenesis. Control and inducible, global knockout (KO) mice were euthanized at 3 and 6 mo of age (early and late stage) to evaluate kidney disease progression, small and large intestinal integrity, and inflammation. Early-stage KO mice displayed mild cystic kidneys and tubular injury with preserved kidney function. Intestinal epithelial barrier was tighter in KO mice, which was associated with higher expression of cell-cell epithelial integrity markers. However, there was no evidence of local or systemic inflammation in either genotype. Late-stage KO mice had severely cystic, impaired kidneys with increased expression of integrity markers, tubular injury, and inflammation. Intestinal epithelial barrier was leakier in late-stage KO mice, accompanied by gene reduction of integrity markers, increased inflammation, and elevated water and sodium channel expression. Gut motility and fecal water excretion were increased in KO compared with flox mice irrespective of age. Overall, kidney injury appears to precede intestinal injury in ADPKD, whereby the intestinal barrier becomes leaky as cystogenesis progresses. Though autosomal dominant polycystic kidney disease (ADPKD) is a multisystem disorder, this is the first study to explore a kidney-gut contribution to disease progression. We identified a tightened intestinal epithelial barrier in early PKD, which becomes leaky as kidneys become more cystic, accompanied by a sustained loss of fecal water. Given the only approved ADPKD therapeutic yields adverse aquaretic events, this study emphasizes the need to evaluate extrarenal water loss in patients before prescribing.

摘要

大多数常染色体显性多囊肾病(ADPKD)患者因种系突变而出现肾囊肿。在肾脏中,(此处原文缺失关键信息,无法准确翻译)缺失会损害上皮细胞完整性并增加巨噬细胞浸润,从而促进囊肿生长。尽管巨噬细胞作为体内最大的炎症细胞库发挥着作用,但肠道中是否存在类似表型尚待阐明。我们推测,在快速囊肿形成之前,(此处原文缺失关键信息,无法准确翻译)缺失会导致肠道上皮屏障渗漏并增加炎症反应。对对照小鼠和可诱导的全身性(此处原文缺失关键信息,无法准确翻译)基因敲除(KO)小鼠在3个月和6个月龄(早期和晚期)实施安乐死,以评估肾脏疾病进展、小肠和大肠的完整性以及炎症情况。早期KO小鼠表现出轻度肾囊肿和肾小管损伤,但肾功能保持正常。KO小鼠的肠道上皮屏障更紧密,这与细胞间上皮完整性标志物的高表达相关。然而,两种基因型均未出现局部或全身炎症的迹象。晚期KO小鼠患有严重的肾囊肿,肾功能受损,完整性标志物表达增加、肾小管损伤并伴有炎症。晚期KO小鼠的肠道上皮屏障更易渗漏,同时完整性标志物基因表达减少、炎症增加以及水和钠通道表达升高。与flox小鼠相比,无论年龄大小,KO小鼠的肠道蠕动和粪便水排泄均增加。总体而言,在ADPKD中,肾脏损伤似乎先于肠道损伤出现,随着囊肿形成的进展,肠道屏障会变得渗漏。尽管常染色体显性多囊肾病(ADPKD)是一种多系统疾病,但这是首次探索肾脏 - 肠道对疾病进展影响的研究。我们发现早期多囊肾病(PKD)患者的肠道上皮屏障收紧,随着肾脏囊肿增多,该屏障会变得渗漏,并伴有粪便水持续流失。鉴于唯一获批的ADPKD治疗药物会产生不良的水利尿事件,本研究强调在开处方前评估患者肾外失水情况的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255f/12176450/ab598c494e43/nihms-2085890-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255f/12176450/3c3a417a702d/nihms-2085890-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255f/12176450/17de6a80efa2/nihms-2085890-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255f/12176450/e0019b969614/nihms-2085890-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255f/12176450/797c799a4455/nihms-2085890-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255f/12176450/8868af443f4d/nihms-2085890-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255f/12176450/b9a2bc1ac850/nihms-2085890-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255f/12176450/96cbca48177e/nihms-2085890-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255f/12176450/ab598c494e43/nihms-2085890-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255f/12176450/3c3a417a702d/nihms-2085890-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255f/12176450/17de6a80efa2/nihms-2085890-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255f/12176450/e0019b969614/nihms-2085890-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255f/12176450/797c799a4455/nihms-2085890-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255f/12176450/8868af443f4d/nihms-2085890-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255f/12176450/b9a2bc1ac850/nihms-2085890-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255f/12176450/96cbca48177e/nihms-2085890-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255f/12176450/ab598c494e43/nihms-2085890-f0009.jpg

相似文献

1
Intestinal barrier function declines during polycystic kidney disease progression.在多囊肾病进展过程中,肠道屏障功能会下降。
Am J Physiol Renal Physiol. 2025 Feb 1;328(2):F218-F229. doi: 10.1152/ajprenal.00058.2024. Epub 2024 Dec 18.
2
The impact of maternal obesity on polycystic kidney disease progression in a mouse model.母体肥胖对小鼠模型中多囊肾病进展的影响。
Am J Physiol Renal Physiol. 2025 Mar 1;328(3):F316-F327. doi: 10.1152/ajprenal.00227.2024. Epub 2025 Feb 5.
3
Polycystic Kidney Disease, Autosomal Dominant常染色体显性多囊肾病
4
The cystogenic effects of ouabain in autosomal dominant polycystic kidney disease require cell caveolae.哇巴因在常染色体显性多囊肾病中的致囊肿作用需要细胞小窝。
Exp Cell Res. 2025 Jan 1;444(1):114356. doi: 10.1016/j.yexcr.2024.114356. Epub 2024 Nov 23.
5
Interventions for preventing the progression of autosomal dominant polycystic kidney disease.用于预防常染色体显性遗传性多囊肾病进展的干预措施。
Cochrane Database Syst Rev. 2024 Oct 2;10(10):CD010294. doi: 10.1002/14651858.CD010294.pub3.
6
Identification of polycystin 2 missense mutants targeted for endoplasmic reticulum-associated degradation.鉴定靶向内质网相关降解的多囊蛋白2错义突变体。
Am J Physiol Cell Physiol. 2025 Feb 1;328(2):C483-C499. doi: 10.1152/ajpcell.00776.2024. Epub 2024 Dec 23.
7
Kidney stone formation in a novel murine model of polycystic kidney disease.多囊肾病新型小鼠模型中的肾结石形成。
Am J Physiol Renal Physiol. 2022 Jul 1;323(1):F59-F68. doi: 10.1152/ajprenal.00165.2021. Epub 2022 Mar 28.
8
Inactivation of / in renal epithelial cells drives infantile nephronophthisis like phenotypes in mouse.在肾上皮细胞中失活会导致小鼠出现类似婴儿型肾单位肾痨的表型。
Elife. 2023 Mar 15;12:e82395. doi: 10.7554/eLife.82395.
9
Interventions for preventing the progression of autosomal dominant polycystic kidney disease.预防常染色体显性多囊肾病进展的干预措施。
Cochrane Database Syst Rev. 2015 Jul 14;2015(7):CD010294. doi: 10.1002/14651858.CD010294.pub2.
10
Targeting TRPM3 as a potential therapeutic approach for autosomal dominant polycystic kidney disease.将TRPM3作为常染色体显性多囊肾病的一种潜在治疗方法。
Sci Rep. 2025 Feb 8;15(1):4714. doi: 10.1038/s41598-025-89200-z.

本文引用的文献

1
Amino acid metabolism in kidney health and disease.肾脏健康与疾病中的氨基酸代谢。
Nat Rev Nephrol. 2024 Dec;20(12):771-788. doi: 10.1038/s41581-024-00872-8. Epub 2024 Aug 28.
2
Lcn2 deficiency accelerates the infection of Escherichia coli O157:H7 by disrupting the intestinal barrier function.Lcn2 缺乏通过破坏肠道屏障功能加速大肠杆菌 O157:H7 的感染。
Microb Pathog. 2023 Dec;185:106435. doi: 10.1016/j.micpath.2023.106435. Epub 2023 Nov 4.
3
Aryl hydrocarbon receptor (AhR) and pregnane X receptor (PXR) play both distinct and common roles in the regulation of colon homeostasis and intestinal carcinogenesis.
芳香烃受体 (AhR) 和孕烷 X 受体 (PXR) 在调节结肠稳态和肠道肿瘤发生中发挥着独特而又共同的作用。
Biochem Pharmacol. 2023 Oct;216:115797. doi: 10.1016/j.bcp.2023.115797. Epub 2023 Sep 9.
4
Loss of Pkd1 limits susceptibility to colitis and colorectal cancer.多囊蛋白1的缺失限制了对结肠炎和结直肠癌的易感性。
Oncogenesis. 2023 Aug 5;12(1):40. doi: 10.1038/s41389-023-00486-y.
5
Accelerated cystogenesis by dietary protein load is dependent on, but not initiated by kidney macrophages.饮食蛋白负荷加速囊肿形成依赖于肾巨噬细胞,但并非由肾巨噬细胞启动。
Front Med (Lausanne). 2023 Jul 19;10:1173674. doi: 10.3389/fmed.2023.1173674. eCollection 2023.
6
Tolvaptan for Children and Adolescents with Autosomal Dominant Polycystic Kidney Disease: Randomized Controlled Trial.托伐普坦治疗常染色体显性遗传多囊肾病患儿和青少年患者的随机对照试验
Clin J Am Soc Nephrol. 2023 Jan 1;18(1):36-46. doi: 10.2215/CJN.0000000000000022.
7
The tryptophan-metabolizing enzyme indoleamine 2,3-dioxygenase 1 regulates polycystic kidney disease progression.色氨酸代谢酶吲哚胺 2,3-双加氧酶 1 调节多囊肾病的进展。
JCI Insight. 2023 Jan 10;8(1):e154773. doi: 10.1172/jci.insight.154773.
8
Metabolic reprogramming in a slowly developing orthologous model of polycystic kidney disease.多囊肾病同源模型中缓慢发展的代谢重编程。
Am J Physiol Renal Physiol. 2022 Mar 1;322(3):F258-F267. doi: 10.1152/ajprenal.00262.2021. Epub 2022 Jan 17.
9
Depletion of Lipocalin 2 (LCN2) in Mice Leads to Dysbiosis and Persistent Colonization with Segmented Filamentous Bacteria.敲除小鼠的脂联素 2(LCN2)导致菌群失调和梭状芽胞杆菌的持续定植。
Int J Mol Sci. 2021 Dec 5;22(23):13156. doi: 10.3390/ijms222313156.
10
Action Mode of Gut Motility, Fluid and Electrolyte Transport in Chronic Constipation.慢性便秘中肠道运动、液体及电解质转运的作用模式
Front Pharmacol. 2021 Jul 27;12:630249. doi: 10.3389/fphar.2021.630249. eCollection 2021.